Safety and Immunogenicity of a Booster Vaccination by CoronaVac or BNT162b2 in Previously Two-Dose Inactivated Virus Vaccinated Individuals with Negative Neutralizing Antibody

COVID-19 has swept across the globe since 2019 and repeated waves of infection have been caused by different variants of the original SARS-CoV-2 (wild type), with the Omicron and Delta variants having dominated recently. Vaccination is among the most important measures in the absence of widespread u...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Kristi Tsz-Wan, Lai Wan Loong, Emilie Yuen-Ting, Fung, Terry Ling-Hiu, Luk, Luke Wing-Pan, Lau, Chor-Chiu, Zee, Jonpaul Sze-Tsing, Ma, Edmond Shiu-Kwan, Tang, Bone Siu-Fai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025305/
https://www.ncbi.nlm.nih.gov/pubmed/35455305
http://dx.doi.org/10.3390/vaccines10040556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025305/
https://www.ncbi.nlm.nih.gov/pubmed/35455305
http://dx.doi.org/10.3390/vaccines10040556

Ejemplares similares